Cogent Biosciences, Inc.·4

Jul 6, 7:08 PM ET

Ros Matthew 4

4 · Cogent Biosciences, Inc. · Filed Jul 6, 2021

Insider Transaction Report

Form 4
Period: 2021-07-01
Ros Matthew
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-07-01$4.78/sh+2,225$10,6252,225 total
    Exercise: $8.02Exp: 2031-07-01Common Stock (2,225 underlying)
Footnotes (2)
  • [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.
  • [F2]This option is fully vested at time of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION